Literature DB >> 20133896

Increased serum hepcidin and alterations in blood iron parameters associated with asymptomatic P. falciparum and P. vivax malaria.

Quirijn de Mast1, Din Syafruddin, Stephan Keijmel, Teun Olde Riekerink, Oktavian Deky, Puji B Asih, Dorine W Swinkels, Andre J van der Ven.   

Abstract

BACKGROUND: Asymptomatic Plasmodium spp. infections and anemia are highly prevalent conditions in tropical regions. We studied whether asymptomatic parasitemia induces hepcidin- and/or cytokine-mediated iron maldistribution and anemia. DESIGN AND METHODS: A group of 1197 Indonesian schoolchildren, aged 5-15 years, were screened by microscopy for the presence of parasitemia. Concentrations of hemoglobin, serum hepcidin and parameters of iron status and inflammation were determined at baseline and 4 weeks after antimalarial treatment.
RESULTS: Asymptomatic P. falciparum and P. vivax parasitemia were detected in 73 (6.1%) and 18 (1.5%) children, respectively, of whom 84% and 83% had a C-reactive protein concentration below 5 mg/L. Children with P. falciparum or P. vivax parasitemia had significantly lower hemoglobin concentrations than 17 aparasitemic controls (12.6 and 12.2 g/dL versus 14.4 g/dL; P<0.01), together with significantly higher serum hepcidin concentrations (5.2 and 5.6 nM versus 3.1 nM; P<0.05). The latter was associated with signs of iron maldistribution with higher ferritin concentrations and lower values of serum iron concentration, transferrin saturation and erythrocyte mean cell volume. Concentrations of growth differentiation factor 15 were similar across groups. Antimalarial treatment partly reversed these abnormalities and led to a significant increase in hemoglobin concentration.
CONCLUSIONS: Asymptomatic malarial parasitemia is associated with increased hepcidin concentrations and anemia, in the absence of a manifest acute phase response. Prolonged iron maldistribution may be an underestimated cause of anemia. Screening for parasitemia should be performed before starting iron supplementation, as iron therapy may be less effective and even hazardous in these circumstances.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20133896      PMCID: PMC2895029          DOI: 10.3324/haematol.2009.019331

Source DB:  PubMed          Journal:  Haematologica        ISSN: 0390-6078            Impact factor:   9.941


  31 in total

1.  Symptomless Plasmodium vivax infections in native Amazonians.

Authors:  E P Camargo; F Alves; L H Pereira da Silva
Journal:  Lancet       Date:  1999-04-24       Impact factor: 79.321

2.  Effects of routine prophylactic supplementation with iron and folic acid on admission to hospital and mortality in preschool children in a high malaria transmission setting: community-based, randomised, placebo-controlled trial.

Authors:  Sunil Sazawal; Robert E Black; Mahdi Ramsan; Hababu M Chwaya; Rebecca J Stoltzfus; Arup Dutta; Usha Dhingra; Ibrahim Kabole; Saikat Deb; Mashavi K Othman; Fatma M Kabole
Journal:  Lancet       Date:  2006-01-14       Impact factor: 79.321

3.  Hematopoiesis in human malaria.

Authors:  S H Abdalla
Journal:  Blood Cells       Date:  1990

4.  Low prevalence of an acute phase response in asymptomatic children from a malaria-endemic area of Papua New Guinea.

Authors:  Heather Imrie; Freya J I Fowkes; Pascal Michon; Livingstone Tavul; John C Reeder; Karen P Day
Journal:  Am J Trop Med Hyg       Date:  2007-02       Impact factor: 2.345

5.  Urinary hepcidin in congenital chronic anemias.

Authors:  Susan L Kearney; Elizabeta Nemeth; Ellis J Neufeld; Dharma Thapa; Tomas Ganz; David A Weinstein; Melody J Cunningham
Journal:  Pediatr Blood Cancer       Date:  2007-01       Impact factor: 3.167

Review 6.  Iron metabolism and malaria.

Authors:  Andrew M Prentice; Hala Ghattas; Conor Doherty; Sharon E Cox
Journal:  Food Nutr Bull       Date:  2007-12       Impact factor: 2.069

Review 7.  Conclusions and recommendations of the WHO Consultation on prevention and control of iron deficiency in infants and young children in malaria-endemic areas.

Authors: 
Journal:  Food Nutr Bull       Date:  2007-12       Impact factor: 2.069

8.  High levels of GDF15 in thalassemia suppress expression of the iron regulatory protein hepcidin.

Authors:  Toshihiko Tanno; Natarajan V Bhanu; Patricia A Oneal; Sung-Ho Goh; Pamela Staker; Y Terry Lee; John W Moroney; Christopher H Reed; Naomi L C Luban; Rui-Hong Wang; Thomas E Eling; Richard Childs; Tomas Ganz; Susan F Leitman; Suthat Fucharoen; Jeffery L Miller
Journal:  Nat Med       Date:  2007-08-26       Impact factor: 53.440

9.  Malaria: even more chronic in nature than previously thought; evidence for subpatent parasitaemia detectable by the polymerase chain reaction.

Authors:  E Bottius; A Guanzirolli; J F Trape; C Rogier; L Konate; P Druilhe
Journal:  Trans R Soc Trop Med Hyg       Date:  1996 Jan-Feb       Impact factor: 2.184

10.  Malarial anemia: of mice and men.

Authors:  Abigail A Lamikanra; Douglas Brown; Alexandre Potocnik; Climent Casals-Pascual; Jean Langhorne; David J Roberts
Journal:  Blood       Date:  2007-03-06       Impact factor: 22.113

View more
  52 in total

1.  Afebrile Plasmodium falciparum parasitemia decreases absorption of fortification iron but does not affect systemic iron utilization: a double stable-isotope study in young Beninese women.

Authors:  Colin I Cercamondi; Ines M Egli; Ella Ahouandjinou; Romain Dossa; Christophe Zeder; Lamidhi Salami; Harold Tjalsma; Erwin Wiegerinck; Toshihiko Tanno; Richard F Hurrell; Joseph Hounhouigan; Michael B Zimmermann
Journal:  Am J Clin Nutr       Date:  2010-10-06       Impact factor: 7.045

2.  Seasonal Variation in the Epidemiology of Asymptomatic Plasmodium falciparum Infections across Two Catchment Areas in Bongo District, Ghana.

Authors:  Kathryn E Tiedje; Abraham R Oduro; Godfred Agongo; Thomas Anyorigiya; Daniel Azongo; Timothy Awine; Anita Ghansah; Mercedes Pascual; Kwadwo A Koram; Karen P Day
Journal:  Am J Trop Med Hyg       Date:  2017-07       Impact factor: 2.345

3.  Immunoassay-based serum hepcidin reference range measurements in healthy children: differences among age groups.

Authors:  Triantafyllia Sdogou; Charalampos Tsentidis; Dimitrios Gourgiotis; Antonios Marmarinos; Alexandra Gkourogianni; Ioannis Papassotiriou; Theodora Anastasiou; Lydia Kossiva
Journal:  J Clin Lab Anal       Date:  2014-03-22       Impact factor: 2.352

4.  The iron fist: malaria and hepcidin.

Authors:  Narla Mohandas; Christopher D Hillyer
Journal:  Blood       Date:  2014-05-22       Impact factor: 22.113

Review 5.  Hepcidin and iron regulation, 10 years later.

Authors:  Tomas Ganz
Journal:  Blood       Date:  2011-02-23       Impact factor: 22.113

6.  Chronic inflammation and iron metabolism.

Authors:  Erin A Osterholm; Michael K Georgieff
Journal:  J Pediatr       Date:  2015-02-13       Impact factor: 4.406

7.  Circulatory hepcidin is associated with the anti-inflammatory response but not with iron or anemic status in childhood malaria.

Authors:  Florence Burté; Biobele J Brown; Adebola E Orimadegun; Wasiu A Ajetunmobi; Nathaniel K Afolabi; Francis Akinkunmi; Olayinka Kowobari; Samuel Omokhodion; Kikelomo Osinusi; Felix O Akinbami; Wuraola A Shokunbi; Olugbemiro Sodeinde; Delmiro Fernandez-Reyes
Journal:  Blood       Date:  2013-02-04       Impact factor: 22.113

8.  Erythroferrone contributes to hepcidin repression in a mouse model of malarial anemia.

Authors:  Chloé Latour; Myriam F Wlodarczyk; Grace Jung; Aurélie Gineste; Nicolas Blanchard; Tomas Ganz; Marie-Paule Roth; Hélène Coppin; Léon Kautz
Journal:  Haematologica       Date:  2016-09-22       Impact factor: 9.941

9.  Decline in childhood iron deficiency after interruption of malaria transmission in highland Kenya.

Authors:  Anne E P Frosch; Bartholomew N Ondigo; George A Ayodo; John M Vulule; Chandy C John; Sarah E Cusick
Journal:  Am J Clin Nutr       Date:  2014-07-30       Impact factor: 7.045

10.  The iron link between malaria and invasive non-typhoid Salmonella infections.

Authors:  Susanne van Santen; Quirijn de Mast; Dorine W Swinkels; André J A M van der Ven
Journal:  Trends Parasitol       Date:  2013-04-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.